CN104662008B - 四唑化合物的脱保护方法 - Google Patents

四唑化合物的脱保护方法 Download PDF

Info

Publication number
CN104662008B
CN104662008B CN201380049732.3A CN201380049732A CN104662008B CN 104662008 B CN104662008 B CN 104662008B CN 201380049732 A CN201380049732 A CN 201380049732A CN 104662008 B CN104662008 B CN 104662008B
Authority
CN
China
Prior art keywords
compound
formula
salt
represented
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380049732.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN104662008A (zh
Inventor
关雅彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
API Corp
Original Assignee
API Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by API Corp filed Critical API Corp
Publication of CN104662008A publication Critical patent/CN104662008A/zh
Application granted granted Critical
Publication of CN104662008B publication Critical patent/CN104662008B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56Platinum group metals
    • B01J23/58Platinum group metals with alkali- or alkaline earth metals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
CN201380049732.3A 2012-09-26 2013-09-26 四唑化合物的脱保护方法 Expired - Fee Related CN104662008B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP2012-213212 2012-09-26
JP2012213212 2012-09-26
PCT/JP2013/076152 WO2014051008A1 (ja) 2012-09-26 2013-09-26 テトラゾール化合物の脱保護方法

Publications (2)

Publication Number Publication Date
CN104662008A CN104662008A (zh) 2015-05-27
CN104662008B true CN104662008B (zh) 2017-03-08

Family

ID=50388403

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380049732.3A Expired - Fee Related CN104662008B (zh) 2012-09-26 2013-09-26 四唑化合物的脱保护方法

Country Status (6)

Country Link
US (1) US9527821B2 (enExample)
EP (1) EP2902385B1 (enExample)
JP (1) JP5881837B2 (enExample)
CN (1) CN104662008B (enExample)
IN (1) IN2015DN02241A (enExample)
WO (1) WO2014051008A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624181B2 (en) 2012-08-31 2017-04-18 Api Corporation Method for producing biaryl compound
CN105418593A (zh) * 2015-11-25 2016-03-23 蚌埠丰原涂山制药有限公司 一种奥美沙坦酯关键中间体及奥美沙坦酯的制备方法
CN105481842A (zh) * 2015-12-15 2016-04-13 江苏中邦制药有限公司 一种奥美沙坦酯的制备方法
CN117069704A (zh) * 2023-08-09 2023-11-17 安徽美诺华药物化学有限公司 一种坎地沙坦酯及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104583185A (zh) * 2012-08-31 2015-04-29 株式会社Api 联芳基化合物的制造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2229000C (en) 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
JPH10195063A (ja) * 1996-10-21 1998-07-28 Dai Ichi Seiyaku Co Ltd エチニルチアゾール誘導体
ATE312820T1 (de) 1999-10-28 2005-12-15 Trine Pharmaceuticals Inc Pumpeninhibitoren zur freisetzung von medikamenten
JP2002322054A (ja) 2001-04-26 2002-11-08 Dai Ichi Seiyaku Co Ltd 薬剤排出ポンプ阻害薬
CN1271068C (zh) 2003-03-25 2006-08-23 上海医药工业研究院 一种奥美沙坦酯的制备方法
ITMI20032267A1 (it) 2003-11-21 2005-05-22 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procdimento per la preparzione di valsartan e suoi intermedi
US8076492B2 (en) 2006-10-09 2011-12-13 Cipla Limited Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
US7830311B2 (en) 2007-07-18 2010-11-09 Murata Manufacturing Co., Ltd. Wireless IC device and electronic device
EP2217580B1 (en) 2007-10-12 2011-12-21 ArQule, Inc. Substituted tetrazole compounds and uses thereof
JPWO2011061996A1 (ja) 2009-11-17 2013-04-04 田辺三菱製薬株式会社 ビフェニル誘導体の製法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104583185A (zh) * 2012-08-31 2015-04-29 株式会社Api 联芳基化合物的制造方法

Also Published As

Publication number Publication date
IN2015DN02241A (enExample) 2015-08-21
EP2902385A4 (en) 2016-03-09
JPWO2014051008A1 (ja) 2016-08-22
US9527821B2 (en) 2016-12-27
EP2902385B1 (en) 2019-01-09
JP5881837B2 (ja) 2016-03-09
CN104662008A (zh) 2015-05-27
WO2014051008A1 (ja) 2014-04-03
US20150239854A1 (en) 2015-08-27
EP2902385A1 (en) 2015-08-05

Similar Documents

Publication Publication Date Title
CA2859604C (en) Compounds
KR101368037B1 (ko) 융합 헤테로시클릭 화합물
FI108434B (fi) Menetelmõ farmakologisesti vaikuttavien bentsimidatsolijohdannaisten valmistamiseksi
AU2007208139B2 (en) 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
RS57406B1 (sr) Derivat 4-alkinil imidazola i lekovi koji ga sadrže kao aktivni sastojak
CN103476758B (zh) 一种制备2-乙氧基-1-((2′-((羟氨基)亚氨基甲基)联苯基-4-基)甲基)-1H-苯并[d]咪唑-7-羧酸及其酯的方法
KR101599000B1 (ko) 아연 결합 모이어티를 갖는 헷지호그 길항제
WO2011055270A1 (en) Indole based receptor crth2 antagonists
CN101437818A (zh) At1和eta受体的新的双重作用受体拮抗剂(dara)
CN104662008B (zh) 四唑化合物的脱保护方法
CN106478641A (zh) 瑞博西尼中间体的新合成方法
CN105669520B (zh) 含有色氨酸基本骨架的邻苯二胺类选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
WO2009061730A2 (en) 4-heteroaryl-substituted phenoxyphenylacetic acid
WO2019238103A1 (zh) 吡啶胺基嘧啶衍生物的制备方法及其中间体
CN102712606A (zh) 联苯基衍生物的制备方法
CN115260167A (zh) 一种3-四唑基甲基-1,3,5-三嗪-2,4-二酮类化合物及其制备方法和应用
WO2014067237A1 (zh) 制备替米沙坦的方法及其中间体
CN104016877A (zh) 一种苯基乙酰胺类化合物及在制备米拉贝隆中的应用
WO2014034868A1 (ja) ビアリール化合物の製造方法
CN102731408A (zh) 一种阿齐沙坦中间体及其制备方法
CN104016974A (zh) 阿齐沙坦酯中间体及其合成方法、阿齐沙坦酯的合成方法
CN101166729B (zh) 稠合的杂环化合物
JP2007525504A (ja) 2.5よりも高いpHでオルメサルタンメドキソミルを調製するための方法
Mao et al. Novel and practical synthesis of candesartan cilexetil
AU2015203842A1 (en) Hedgehog antagonists having zinc binding moieties

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170308

CF01 Termination of patent right due to non-payment of annual fee